Patents by Inventor Sekhar S. Surapaneni

Sekhar S. Surapaneni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaryl compounds useful as MK2 inhibitors
    Patent number: 11760763
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: September 19, 2023
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jian Guo, John Malona, Alexander L. Ruchelman, Sekhar S. Surapaneni
  • HETEROARYL COMPOUNDS USEFUL AS MK2 INHIBITORS
    Publication number: 20220064183
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 3, 2022
    Inventors: Jian Guo, John Malona, Alexander L. Ruchelman, Sekhar S. Surapaneni
  • Deuterated analogs of MK2 inhibitors and uses thereof
    Patent number: 11230551
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: January 25, 2022
    Assignee: Celgene CAR LLC
    Inventors: John Malona, Sekhar S. Surapaneni
  • Heteroaryl compounds useful as MK2 inhibitors
    Patent number: 11124525
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: September 21, 2021
    Assignee: Celgene CAR LLC
    Inventors: Jian Guo, John Malona, Alexander L. Ruchelman, Sekhar S. Surapaneni
  • DEUTERATED ANALOGS OF MK2 INHIBITORS AND USES THEREOF
    Publication number: 20210122762
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: March 15, 2018
    Publication date: April 29, 2021
    Inventors: John Malona, Sekhar S. Surapaneni
  • HETEROARYL COMPOUNDS USEFUL AS MK2 INHIBITORS
    Publication number: 20200102325
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: March 15, 2018
    Publication date: April 2, 2020
    Inventors: Jian Guo, John Malona, Alexander L. Ruchelman, Sekhar S. Surapaneni
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20170095475
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: August 12, 2016
    Publication date: April 6, 2017
    Inventors: Richland Wayne Tester, Prasoon Chaturvedi, Zhendong Zhu, Sekhar S. Surapaneni, Lisa Beebe
  • Heteroaryl compounds and uses thereof
    Patent number: 9549927
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: January 24, 2017
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Richland Tester, Prasoon Chaturvedi, Zhendong Zhu, Sekhar S. Surapaneni, Lisa Beebe
  • Heteroaryl compounds and uses thereof
    Patent number: 9415049
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: August 16, 2016
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Richland Tester, Prasoon Chaturvedi, Zhendong Zhu, Sekhar S. Surapaneni, Lisa Beebe
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20160159774
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: December 3, 2015
    Publication date: June 9, 2016
    Inventors: C. Eric Schwartz, Sekhar S. Surapaneni, Karin Irmgard Worm
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20150374690
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 2, 2015
    Publication date: December 31, 2015
    Inventors: Richland Tester, Prasoon Chaturvedi, Zhendong Zhu, Sekhar S. Surapaneni, Lisa Beebe
  • Heteroaryl compounds and uses thereof
    Patent number: 9126950
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: September 8, 2015
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Richland Tester, Prasoon Chaturvedi, Zhendong Zhu, Sekhar S. Surapaneni, Lisa Beebe
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20150174128
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: December 20, 2013
    Publication date: June 25, 2015
    Applicant: Celgene Avilomics Research, Inc.
    Inventors: Richland Tester, Prasoon Chaturvedi, Zhendong Zhu, Sekhar S. Surapaneni, Lisa Beebe
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20140179720
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: December 20, 2013
    Publication date: June 26, 2014
    Applicant: Celgene Avilomics Research, Inc.
    Inventors: Richland Tester, Prasoon Chaturvedi, Zhendong Zhu, Sekhar S. Surapaneni, Lisa Beebe